More than 2 weeks of treatment with cefepime administered by intravenous (IV) push significantly increases the risk of cefepime-induced neutropenia.

The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated to include a 90-second intravenous (IV) push loading dose.. Trogarzo, a CD4-directed post-attachment HIV-1 inhibitor ...

A majority of nurses — 83 percent — reported that they further dilute certain IV push medications for adult patients prior to administration, according to a survey conducted by the Institute ...

The Food and Drug Administration (FDA) has approved Trogarzo ® (ibalizumab-uiyk) for administration by intravenous (IV) push for maintenance dosing.. Trogarzo is a CD4-directed post-attachment ...

The Food and Drug Administration (FDA) has approved the HIV-1 medication ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for administration by intravenous push. Ibalizumab-uiyk, a long-acting ...

A charge to put medicine into a patient's IV line — a "push fee" — is one of them. Sponsor Message. Though the biggest charge on Claire's bill, $9,885.73, was for a CT scan, ...

Reduces maintenance dose from a 15-minute IV infusion to a 30-second, undiluted IV push every two weeksSafety profile of Trogarzo® IV push similar to that of IV infusionNew method of ...

SAN DIEGO, Feb. 26, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class ...